Influence of PSK (Krestin) on resistance to infection of Pseudomonas aeruginosa in tumor-bearing mice
- PMID: 3119242
- DOI: 10.1007/BF00570484
Influence of PSK (Krestin) on resistance to infection of Pseudomonas aeruginosa in tumor-bearing mice
Abstract
C3H/He mice were inoculated with Pseudomonas aeruginosa by various routes 1 day after X5563 transplantation or 4 days after cyclophosphamide (CY) administration. Administration of PSK (Krestin) i.p. or p.o. to the tumor-bearing mice or CY-treated tumor-bearing mice resulted in an increase in survival rates. Viable P. aeruginosa were inoculated i.v. on day 0 into mice inoculated with tumor cells on day -12 and vaccinated with killed P. aeruginosa on day -10, or into mice inoculated with tumor cells on day -15, treated with CY on day -14 and vaccinated on day -10. Resistance to infection, which is enhanced by vaccination, was depressed by tumor burden or treatment with CY, but such depression was prevented by PSK administration.
Similar articles
-
Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK.J Clin Lab Immunol. 1992 Jan;37(1):21-37. J Clin Lab Immunol. 1992. PMID: 1339233
-
Effects of PSK, an antitumor protein-bound polysaccharide, on the surface charge of lymphocytes in X5563-bearing mice.J Clin Lab Immunol. 1987 Sep;24(1):33-7. J Clin Lab Immunol. 1987. PMID: 3681950
-
Effects of PSK on resistance to bacterial infection in splenectomized mice.Oncology. 1988;45(3):224-9. doi: 10.1159/000226566. Oncology. 1988. PMID: 3285280
-
Krestin (PSK).Cancer Treat Rev. 1984 Jun;11(2):131-55. doi: 10.1016/0305-7372(84)90005-7. Cancer Treat Rev. 1984. PMID: 6238674 Review.
-
Mono--and polyvalent Pseudomonas aeruginosa vaccines. Preparation, control and administration.Arch Roum Pathol Exp Microbiol. 1982 Apr-Jun;41(2):105-14. Arch Roum Pathol Exp Microbiol. 1982. PMID: 6816188 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous